Lo: How Should Vaccines Be Financed?
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
MIT Climate Pathways Project Impact Research
MIT Climate Pathways Project Research Insights
MIT Climate Pathways Project News and Media
MIT Climate Pathways Project Impact Stories
Advancing evidence-based climate change solutions through interactive simulations and research insights.
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
By
MIT researchers have developed a methodology for systematically tracking the outcomes of academic licensing transactions as a means of increasing funding to bridging the “valley of death.”
By
A new study led by MIT Sloan Prof. Andrew W. Lo finds that borrowing ideas and tools from the gaming community can improve online teaching techniques and improve learning outcomes for students.
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.